Pieris Pharmaceuticals Inc (PIRS) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering PIRS.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
PIRS Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- PIRS has a less percent of analysts bearish on the stock than nearly 100% of all US stocks.
- Pieris Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is higher than 89.52% of all US stocks.
- Pieris Pharmaceuticals Inc's average analyst price target is higher than 13.77% of Business Services stocks.
- The percentage of analysts bullish on the stock of PIRS is higher than 85% of Business Services stocks.
- The variance in analysts' estimates of PIRS is lower than 20.32% of stocks in the small market cap category.
- PIRS has a greater number of analysts covering the stock than 22.64% of Healthcare stocks.
- Pieris Pharmaceuticals Inc's change in bullishness amongst analysts is lower than nearly 100% of all US stocks.
Is PIRS a Buy, Hold or Sell? See the POWR Ratings now!